SCHEMBL17869764

SCHEMBL17869764

Cc1cccc(NBr)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28007302 0.98 MAPT (0.56)
Hydrochloric Acid SCHEMBL3612344 0.79 GAA (0.55)
SCHEMBL1009206 0.79 NPSR1 (0.86)
SCHEMBL29650380 0.79 NPSR1 (0.86)
SCHEMBL6694995 0.79 GAA (0.65)
SCHEMBL2479722 0.78 GAA (0.60)
Water SCHEMBL8601146 0.77 NPSR1 (0.82)
SCHEMBL29697291 0.77
SCHEMBL9158496 0.77 NPSR1 (0.82)
SCHEMBL306337 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103041855-B Preparation method of catalysts for dichloro-pyridine oxynitride SHANGHAI NOVEL CHEMICAL TECHNOLOGY CO LTD 2014-09-10 CN claimed
US-12018030-B2 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors VALO HEALTH, INC. (US) 2024-06-25 US disclosed
US-20210332052-A1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS VALO HEALTH, INC. 2021-10-28 US disclosed
US-10934299-B2 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors VALO EARLY DISCOVERY, INC. (US) 2021-03-02 US disclosed
CN-110483423-A P2X4 receptor antagonist NIPPON CHEMIPHAR CO 2019-11-22 CN disclosed
CN-110294757-A A kind of copper catalysis one kettle way prepares the synthetic method and application of C-3 thiocarbamoyl imidazoles and pyridine derivatives 青岛科技大学 2019-10-01 CN disclosed
CN-110256258-A A method of photocatalytic synthesis is at more bromoaniline compounds in water phase 福建医科大学 2019-09-20 CN disclosed
CN-110195237-A A method of using bromide as bromating agent, the electro-catalysis in water phase prepares more bromoaniline compounds 福建医科大学 2019-09-03 CN disclosed
CN-110183373-A A kind of optical activity 1- (hetero) aryl indole derivatives and its preparation method and application 浙江大学 2019-08-30 CN disclosed
US-10377760-B2 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors FORMA THERAPEUTICS, INC. (US) 2019-08-13 US disclosed
CN-103209960-A Sulfonamide compounds useful as CYP17 inhibitors BRISTOL MYERS SQUIBB CO 2013-07-17 CN disclosed
CN-101395147-B 1- (benzo [ D ] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane-carboxamide derivatives and related compounds as modulators of ATP-binding cassette transporters for the treatment of cystic fibrosis VERTEX PHARMA 2013-05-29 CN disclosed
CN-102958932-A 5-HT receptor modulators and methods of use thereof ABBVI INC 2013-03-06 CN disclosed
CN-102762226-A Benzonaphthyridine-containing vaccines NOVARTIS AG 2012-10-31 CN disclosed
CN-102464654-A Novel antivirus compound SHANGHAI HONGBO ZHIYUAN MEDICAL TECHNOLOGY CO LTD 2012-05-23 CN disclosed
CN-102015651-A Compounds and compositions as TLR activity modulators IRM LLC 2011-04-13 CN disclosed
CN-101981036-A Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors NOVARTIS AG 2011-02-23 CN disclosed
CN-101970572-A Photocurable composition SEKISUI CHEMICAL CO LTD 2011-02-09 CN disclosed
CN-101743224-A 7-substituted indole mcl-1 inhibitors ABBOTT LAB 2010-06-16 CN disclosed
CN-101641014-A Poly (ADP-ribose) polymerase inhibitors ABBOTT LAB US 2010-02-03 CN disclosed